Background image

terug

An obsession with prescribing perfection

Better Than Well:
American Medicine Meets
The American Dream

by Carl Elliott
Norton 357 pp $26.95
Reviewed by Shannon Brownlee

1     In the late 1960s, the pharmaceutical company Sandoz introduced Serentil, a new
 tranquilizer. Serentil, according to the ad, could ease the “anxiety that comes from not
 fitting in,” a feeling that practically every person on the planet has undoubtedly
 experienced. But Sandoz was prevented from tapping this potentially enormous market
 by the U.S. Food and Drug Administration, which forced the company to withdraw the
 drug and issue a statement to the effect that Serentil was not intended for use in
 everyday, anxiety-provoking situations.
2     Thirty years after Serentil flopped, GlaxoSmithKline launched its own ad campaign
 for Paxil, an antidepressant that could also be used to treat “social phobia.” The
 company sent out press releases describing the disease, provided reporters with lists of
 sufferers willing to speak about their condition, and papered bus shelters with posters
 and the slogan “Imagine Being Allergic to People.” The promotional campaign hardly
 mentioned the drug, let alone the manufacturer, notes author Carl Elliott, because
 pharmaceutical companies have learned the lesson of Serentil: if they want to sell a drug
 that will “take the edge off some sharply uncomfortable aspect of American social life,”
 as Elliott puts it, they first need to persuade Americans that their discomfort is due to a
 bona fide medical problem. “SmithKline does not need to sell Paxil,” he writes. “What
 they need to sell is social phobia.”
3     That, in a nutshell, is the pattern of America’s obsession with enhancement
 technology: drugs and procedures that are supposed to make us more contented, calmer,
 sexier. In a word, better. “Doctors begin using a new drug or surgical procedure that
 looks as much like cosmetic intervention … as a proper medical treatment,” Elliott
 writes. The technology triggers a heated debate. But in the end, the technology is
 accepted as a part of ordinary American life.
4     The acceptance of enhancement has been aided, says Elliot, by the American devotion
 to the self. “We tend to see ourselves as the managers of life projects,” writes Elliott,
 managers who must search for ways to make our lives better, richer, more
 psychologically healthy. But this notion of life as a project leads to a degree of moral
 uncertainty, and to the belief that we are solely responsible for the outcome of our
 endeavors. To that end, we have drafted medicine and technology into the service of
 having good lives rather than being good people.
5     Better Than Well is a superbly crafted book. Lucidly written, often funny, it offers a
 penetrating look at our self-obsessed, over-medicalized, enhancement-addicted society.
 But Elliott goes further than this. Better Than Well also prepares the ground for
 thinking about the difficult and contentious issues surrounding gene therapy and genetic
 engineering.
6     Bioethicists draw a line between so-called therapeutic technologies, which are
 deemed moral, and enhancement technologies, which are not. Thus genetic therapy that
 can cure a disease such as cystic fibrosis is good, but genetic engineering to give a child
 greater intelligence is bad. The problem with this construction, as Elliott makes clear, is
 that the distinction between treatment and enhancement gets a little blurry in a society
 that has become adept at turning many aspects of ordinary life into medical problems. Is
 it enhancement to give growth hormone to increase the stature of boys who will achieve
 below-average height? Or therapy to protect their egos? And once biotechnologists find
 the genes for stature, will we want to ensure that all our sons are above average and all
 our daughters do not grow too tall?
7     The ability to alter the genes in embryos is coming soon to a culture that sees selfexpression
 and identity as commodities that can be purchased. The implication of this
 eloquent, disturbing book is that it will be very difficult to stop genetic enhancement, or
 even slow it down.
 
 The Washington Post